Chapter 41: Pediatric Immune Problems and Infectious Diseases

The chapter extensively covers HIV and AIDS in children, emphasizing that Human Immunodeficiency Virus targets CD4+ T cells and progressively compromises immune function, with particular attention to perinatal transmission routes and the heightened vulnerability to opportunistic infections such as Pneumocystis jiroveci pneumonia during critical developmental windows. Diagnostic approaches vary by age, utilizing polymerase chain reaction and antigen detection methods in infants to circumvent false positives from maternal antibodies, while treatment relies on combination antiretroviral therapy to suppress viral replication and preserve immune competence. Special consideration is given to immunization strategies, as children with symptomatic HIV or severe immunosuppression must receive only inactivated vaccine formulations while avoiding live attenuated vaccines. The chapter then systematically examines classical pediatric communicable diseases including rubeola, roseola infantum, rubella, mumps, varicella, pertussis, diphtheria, poliomyelitis, and scarlet fever, detailing their characteristic clinical presentations, transmission mechanisms, and requisite infection control measures. Each disease is contextualized within broader concepts of incubation periods, prodromal symptoms, and distinguishing rash characteristics that aid in clinical recognition. The chapter addresses contemporary infectious threats including community-associated methicillin-resistant Staphylococcus aureus, seasonal influenza, and coronavirus disease, with particular emphasis on emerging complications such as Pediatric Inflammatory Multisystem Syndrome following COVID-19 infection. Throughout, the chapter integrates interprofessional management strategies, caregiver education requirements, and evidence-based preventive measures including vaccination protocols, hygiene practices, and environmental control techniques essential for reducing disease transmission in pediatric settings.